Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Status Completed

Clinical Trial Summary

Tourette's Syndrome is a neurological disease characterized by motor and vocal tics. It has been hypothesized that abnormal interactions of dopamine with its receptors may cause the tics. The purpose of this study is to test the hypothesis that a drug (ecopipam) that selectively blocks dopamine D1/D5 receptors can reduce the frequency and severity of the tics.

Clinical Trial Description

This is a double blind, randomized, placebo-controlled crossover study to determine whether ecopipam can reduce the symptoms of Tourette's in children age 7-17 years. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02102698
Study type	Interventional
Source	Emalex Biosciences Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	March 2014
Completion date	December 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00965211` - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome	N/A
Recruiting	`NCT00152750` - Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD	Phase 4
Terminated	`NCT00226824` - Safety Study of Galantamine in Tic Disorders	Phase 4
Completed	`NCT00241176` - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder	Phase 4
Completed	`NCT01244633` - Ecopipam Treatment of Tourette Syndrome	Phase 1/Phase 2
Recruiting	`NCT04805385` - Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome	N/A
Completed	`NCT00026000` - Brain Activation in Vocal and Motor Tics	N/A
Terminated	`NCT00001260` - Brain Tissue Collection for Neuropathological Studies
Withdrawn	`NCT02112253` - Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome	Phase 1/Phase 2
Withdrawn	`NCT01133353` - A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome	Phase 2
Completed	`NCT02205918` - Brain-Behavior Interactions in Tic Suppression
Terminated	`NCT00282139` - Aripiprazole in the Treatment of Tourette's Syndrome	N/A
Completed	`NCT03042507` - Psychosocial Intervention for Young Children With Chronic Tics	N/A
Completed	`NCT01019343` - Physiological Investigations of Movement Disorders	N/A
Completed	`NCT02619084` - Subthalamic Stimulation in Tourette's Syndrome	Phase 2
Completed	`NCT00368433` - Hypersensitivity in Tourette Syndrome	N/A
Withdrawn	`NCT01475383` - Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome	Phase 2
Not yet recruiting	`NCT06361004` - Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome	N/A
Completed	`NCT00139308` - High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome	Phase 1